Department of Health and Human Services$1.1M obligationsEnds Dec 18, 2021
Federal contract award
75N96021F00016
TASK ORDER 16: USE OF INHALED HYALURONAN IN PATIENTS WITH SEVERE COVID-19
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTE OF HEALTH NIEHS |
| NAICS | 541712 |
| PSC | AJ11 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH |
| Parent award / vehicle | HHSN273201600002I |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $224.8K |
| Current contract value | $224.8K |
| Potential contract value / ceiling | $224.8K |
| Start date | Feb 26, 2021 |
| Current end date | Feb 28, 2022 |
| Potential end date | Feb 28, 2022 |
| Latest award activity | Aug 5, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 5, 2026 | P00002 | $-391 | FY26 UDO INITIATIVE - TASK ORDER 16: USE OF INHALED HYALURONAN IN PATIENTS WITH SEVERE COVID-19 |
| Apr 19, 2021 | P00001 | $75.2K | TASK ORDER 16: USE OF INHALED HYALURONAN IN PATIENTS WITH SEVERE COVID-19 |
| Feb 26, 2021 | 0 | $150.0K | TASK ORDER 16: USE OF INHALED HYALURONAN IN PATIENTS WITH SEVERE COVID-19 |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.